Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.

Horlings HM, van Laar RK, Kerst JM, Helgason HH, Wesseling J, van der Hoeven JJ, Warmoes MO, Floore A, Witteveen A, Lahti-Domenici J, Glas AM, Van't Veer LJ, de Jong D.

J Clin Oncol. 2008 Sep 20;26(27):4435-41. doi: 10.1200/JCO.2007.14.6969.

PMID:
18802156
2.

Molecular classification of unknown primary cancer.

Bender RA, Erlander MG.

Semin Oncol. 2009 Feb;36(1):38-43. doi: 10.1053/j.seminoncol.2008.10.002. Review.

PMID:
19179186
3.

Metastatic adenocarcinoma of unknown primary origin.

Hammar SP.

Hum Pathol. 1998 Dec;29(12):1393-402. Review.

PMID:
9865824
4.

[Liver metastases with unknown primary site].

Drug VL, Popa I, Cijevschi C, Miron L, Mitrică D, Stanciu C.

Rev Med Chir Soc Med Nat Iasi. 2003 Apr-Jun;107(2):298-305. Review. Romanian.

PMID:
14755931
5.

Molecular classification of cancers of unknown primary site.

Greco FA, Erlander MG.

Mol Diagn Ther. 2009 Dec 1;13(6):367-73. doi: 10.2165/11530360-000000000-00000. Review.

PMID:
19925034
6.

Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin.

Monzon FA, Koen TJ.

Arch Pathol Lab Med. 2010 Feb;134(2):216-24. doi: 10.1043/1543-2165-134.2.216. Review.

PMID:
20121609
7.

Is immunostaining with HAM56 antibody useful in identifying ovarian origin of metastatic adenocarcinomas?

Cheung AN, Chiu PM, Khoo US.

Hum Pathol. 1997 Jan;28(1):91-4. Review.

PMID:
9013838
8.

[Molecular diagnostic methods designed for clinical approach to cancer of unknown origin].

Fujita Y, Nishio K.

Gan To Kagaku Ryoho. 2009 Jun;36(6):923-6. Review. Japanese.

PMID:
19542713
9.

Diagnostic strategies for unknown primary cancer.

Varadhachary GR, Abbruzzese JL, Lenzi R.

Cancer. 2004 May 1;100(9):1776-85. Review.

10.

Hunting the primary: novel strategies for defining the origin of tumours.

Dennis JL, Oien KA.

J Pathol. 2005 Jan;205(2):236-47. Review.

PMID:
15641019
11.

Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.

Pentheroudakis G, Greco FA, Pavlidis N.

Cancer Treat Rev. 2009 May;35(3):221-7. doi: 10.1016/j.ctrv.2008.10.003. Review.

PMID:
19046817
12.

[Cutaneous metastases from adenocarcinoma of unknown primary site].

Bordel Gómez MT, Used Aznar MM.

Actas Dermosifiliogr. 2006 Dec;97(10):662-5. Review. Spanish.

PMID:
17173831
13.

Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.

Greco FA.

Curr Treat Options Oncol. 2013 Dec;14(4):634-42. doi: 10.1007/s11864-013-0257-1. Review.

PMID:
23990214
14.

Metastasis of unknown origin.

Haskell CM, Cochran AJ, Barsky SH, Steckel RJ.

Curr Probl Cancer. 1988 Jan-Feb;12(1):5-58. Review.

PMID:
3067982
15.

Empirical chemotherapy for adenocarcinoma of unknown primary tumor site.

Sporn JR, Greenberg BR.

Semin Oncol. 1993 Jun;20(3):261-7. Review.

PMID:
7684858
16.

Cancer of unknown primary site: evolving understanding and management of patients.

Greco FA.

Clin Adv Hematol Oncol. 2012 Aug;10(8):518-24. Review.

PMID:
23073050
17.

Overview of various techniques/platforms with critical evaluation of each.

Agwa E, Ma PC.

Curr Treat Options Oncol. 2013 Dec;14(4):623-33. doi: 10.1007/s11864-013-0259-z. Review.

PMID:
24243164
18.

Diagnosis of uncertain primary tumors with the Pathwork tissue-of-origin test.

Monzon FA, Dumur CI.

Expert Rev Mol Diagn. 2010 Jan;10(1):17-25. doi: 10.1586/erm.09.75. Review.

PMID:
20014919
19.

[The initial CUP situation and CUP syndrome: pathological diagnostics].

Moll R.

Pathologe. 2009 Dec;30 Suppl 2:161-7. doi: 10.1007/s00292-009-1193-5. Review. German.

PMID:
19816686
20.

Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care.

Hainsworth JD, Greco FA.

Virchows Arch. 2014 Apr;464(4):393-402. doi: 10.1007/s00428-014-1545-2. Review.

PMID:
24487792

Supplemental Content

Support Center